Listed

Korro Bio, Inc.

KRRONasdaqCIK 1703647HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$20.1m, Q2 FY2026
Net income−$18.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure2.3Revenue, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure2.6Revenue, Q1 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure1.5Revenue, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure1.1Revenue, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure1.3Revenue, Q4 FY2025, three months to 2025-12-31$1.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Research and development$m14.0Research and development, Q3 FY2023, three months to 2023-09-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure15.4Research and development, Q4 FY2023, three months to 2023-12-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure13.6Research and development, Q1 FY2024, three months to 2024-03-31$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure17.1Research and development, Q2 FY2024, three months to 2024-06-30$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure16.0Research and development, Q3 FY2024, three months to 2024-09-30$16.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure17.0Research and development, Q4 FY2024, three months to 2024-12-31$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure19.7Research and development, Q1 FY2025, three months to 2025-03-31$19.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure20.1Research and development, Q2 FY2025, three months to 2025-06-30$20.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure13.8Research and development, Q3 FY2025, three months to 2025-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure11.0Research and development, Q4 FY2025, three months to 2025-12-31$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure13.0Research and development, Q1 FY2026, three months to 2026-03-31$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure13.6Research and development, Q2 FY2026, three months to 2026-06-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Operating income$m(19.1)Operating income, Q3 FY2023, three months to 2023-09-30−$19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure(26.9)Operating income, Q4 FY2023, three months to 2023-12-31−$26.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure(21.5)Operating income, Q1 FY2024, three months to 2024-03-31−$21.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure(24.1)Operating income, Q2 FY2024, three months to 2024-06-30−$24.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure(23.3)Operating income, Q3 FY2024, three months to 2024-09-30−$23.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(23.0)Operating income, Q4 FY2024, three months to 2024-12-31−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(25.0)Operating income, Q1 FY2025, three months to 2025-03-31−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(27.2)Operating income, Q2 FY2025, three months to 2025-06-30−$27.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(19.2)Operating income, Q3 FY2025, three months to 2025-09-30−$19.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(50.4)Operating income, Q4 FY2025, three months to 2025-12-31−$50.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(20.4)Operating income, Q1 FY2026, three months to 2026-03-31−$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(20.1)Operating income, Q2 FY2026, three months to 2026-06-30−$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0000950170-23-058171.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$17.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure0.1Income tax, Q4 FY2024, three months to 2024-12-31$103.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure0.6Income tax, Q4 FY2025, three months to 2025-12-31$636.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$95.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$108.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Net income$m(18.5)Net income, Q3 FY2023, three months to 2023-09-30−$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure(25.4)Net income, Q4 FY2023, three months to 2023-12-31−$25.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure(19.6)Net income, Q1 FY2024, three months to 2024-03-31−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(21.8)Net income, Q2 FY2024, three months to 2024-06-30−$21.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(21.0)Net income, Q3 FY2024, three months to 2024-09-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(21.2)Net income, Q4 FY2024, three months to 2024-12-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Net income, Q1 FY2025, three months to 2025-03-31−$23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(25.8)Net income, Q2 FY2025, three months to 2025-06-30−$25.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(18.1)Net income, Q3 FY2025, three months to 2025-09-30−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure(50.0)Net income, Q4 FY2025, three months to 2025-12-31−$50.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(19.6)Net income, Q1 FY2026, three months to 2026-03-31−$19.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(18.9)Net income, Q2 FY2026, three months to 2026-06-30−$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Diluted EPS$ per share(65.08)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$65.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figurenot reported(2.44)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure(2.43)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure(2.26)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figurenot reported(2.49)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(2.74)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(1.92)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figurenot reported(1.69)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(1.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Basic EPS$ per share(65.08)Basic EPS, Q3 FY2023, three months to 2023-09-30−$65.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figurenot reported(2.44)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure(2.43)Basic EPS, Q2 FY2024, three months to 2024-06-30−$2.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure(2.26)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figurenot reported(2.49)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(2.74)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure(1.92)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figurenot reported(1.69)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(1.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure

Balance sheet

Cash and equivalents$24.9m, Q2 FY2026
Shareholders' equity$103.2m, Q2 FY2026
Line itemUnitperiod not labelled2023-11-03FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m36.6Cash and equivalents, period not labelled, at 2023-11-03$36.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure166Cash and equivalents, FY2023, at 2023-12-31$166.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure139Cash and equivalents, Q1 FY2024, at 2024-03-31$138.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure91.2Cash and equivalents, Q2 FY2024, at 2024-06-30$91.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure63.2Cash and equivalents, Q3 FY2024, at 2024-09-30$63.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure55.6Cash and equivalents, FY2024, at 2024-12-31$55.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure64.1Cash and equivalents, Q1 FY2025, at 2025-03-31$64.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure33.6Cash and equivalents, Q2 FY2025, at 2025-06-30$33.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure24.2Cash and equivalents, Q3 FY2025, at 2025-09-30$24.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure21.8Cash and equivalents, FY2025, at 2025-12-31$21.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure61.7Cash and equivalents, Q1 FY2026, at 2026-03-31$61.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure24.9Cash and equivalents, Q2 FY2026, at 2026-06-30$24.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Current assets$mnot reported173Current assets, FY2023, at 2023-12-31$172.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure146Current assets, Q1 FY2024, at 2024-03-31$145.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure164Current assets, Q2 FY2024, at 2024-06-30$163.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure153Current assets, Q3 FY2024, at 2024-09-30$152.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure132Current assets, FY2024, at 2024-12-31$131.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure121Current assets, Q1 FY2025, at 2025-03-31$121.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure103Current assets, Q2 FY2025, at 2025-06-30$102.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure98.2Current assets, Q3 FY2025, at 2025-09-30$98.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure82.4Current assets, FY2025, at 2025-12-31$82.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure120Current assets, Q1 FY2026, at 2026-03-31$120.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure121Current assets, Q2 FY2026, at 2026-06-30$120.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Total assets$mnot reported222Total assets, FY2023, at 2023-12-31$221.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure198Total assets, Q1 FY2024, at 2024-03-31$198.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure250Total assets, Q2 FY2024, at 2024-06-30$249.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure244Total assets, Q3 FY2024, at 2024-09-30$243.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure226Total assets, FY2024, at 2024-12-31$226.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure202Total assets, Q1 FY2025, at 2025-03-31$202.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure180Total assets, Q2 FY2025, at 2025-06-30$180.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure162Total assets, Q3 FY2025, at 2025-09-30$161.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure114Total assets, FY2025, at 2025-12-31$113.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure184Total assets, Q1 FY2026, at 2026-03-31$183.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure163Total assets, Q2 FY2026, at 2026-06-30$163.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Current liabilities$mnot reported19.5Current liabilities, FY2023, at 2023-12-31$19.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure11.1Current liabilities, Q1 FY2024, at 2024-03-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure12.3Current liabilities, Q2 FY2024, at 2024-06-30$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure13.6Current liabilities, Q3 FY2024, at 2024-09-30$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure15.0Current liabilities, FY2024, at 2024-12-31$15.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure12.9Current liabilities, Q1 FY2025, at 2025-03-31$12.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure17.2Current liabilities, Q2 FY2025, at 2025-06-30$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure14.6Current liabilities, Q3 FY2025, at 2025-09-30$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure11.9Current liabilities, FY2025, at 2025-12-31$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure14.8Current liabilities, Q1 FY2026, at 2026-03-31$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure12.6Current liabilities, Q2 FY2026, at 2026-06-30$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Total liabilities$mnot reported51.8Total liabilities, FY2023, at 2023-12-31$51.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0000950170-25-040759.Report this figure46.6Total liabilities, Q1 FY2024, at 2024-03-31$46.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure51.5Total liabilities, Q2 FY2024, at 2024-06-30$51.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure63.9Total liabilities, Q3 FY2024, at 2024-09-30$63.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure65.8Total liabilities, FY2024, at 2024-12-31$65.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure63.3Total liabilities, Q1 FY2025, at 2025-03-31$63.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure65.3Total liabilities, Q2 FY2025, at 2025-06-30$65.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure62.5Total liabilities, Q3 FY2025, at 2025-09-30$62.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure62.1Total liabilities, FY2025, at 2025-12-31$62.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure64.0Total liabilities, Q1 FY2026, at 2026-03-31$64.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure60.2Total liabilities, Q2 FY2026, at 2026-06-30$60.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$mnot reported170Shareholders' equity, FY2023, at 2023-12-31$169.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2026-03-12, accession 0001193125-26-104156.Report this figure151Shareholders' equity, Q1 FY2024, at 2024-03-31$151.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure198Shareholders' equity, Q2 FY2024, at 2024-06-30$198.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure180Shareholders' equity, Q3 FY2024, at 2024-09-30$179.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure160Shareholders' equity, FY2024, at 2024-12-31$160.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure139Shareholders' equity, Q1 FY2025, at 2025-03-31$139.0m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure115Shareholders' equity, Q2 FY2025, at 2025-06-30$115.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure99.0Shareholders' equity, Q3 FY2025, at 2025-09-30$99.0m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure51.4Shareholders' equity, FY2025, at 2025-12-31$51.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure120Shareholders' equity, Q1 FY2026, at 2026-03-31$119.6m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure103Shareholders' equity, Q2 FY2026, at 2026-06-30$103.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure

Cash flow

Operating cash flow−$17.0m, Q2 FY2026
Capital expenditure$37.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125362. Derived: 9-month figure less the 6-month figure.Report this figure(21.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure(21.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$21.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure(14.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-106912. Derived: 6-month figure less the 3-month figure.Report this figure(16.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277572. Derived: 9-month figure less the 6-month figure.Report this figure(7.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(24.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(19.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$19.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336707. Derived: 6-month figure less the 3-month figure.Report this figure(17.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277572. Derived: 9-month figure less the 6-month figure.Report this figure(17.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure(16.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure(17.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336707. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$246.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125362. Derived: 9-month figure less the 6-month figure.Report this figure1.7Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0000950170-25-040759. Derived: 12-month figure less the 9-month figure.Report this figure5.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure6.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$6.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-106912. Derived: 6-month figure less the 3-month figure.Report this figure4.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$4.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277572. Derived: 9-month figure less the 6-month figure.Report this figure1.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$119.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336707. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$175.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277572. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$84.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104156. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336707. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)17.62m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares35.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3035,247,680 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-058171.Report this figure0.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31271,522 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059493.Report this figure0.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30276,482 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096189.Report this figure0.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30284,156 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125362.Report this figure8.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-318,019,626 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065800.Report this figure9.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-308,986,545 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-106912.Report this figure9.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-309,303,218 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure9.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-319,384,266 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure9.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-309,390,542 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure9.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-309,391,559 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277572.Report this figure11.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3111,598,717 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210303.Report this figure17.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3017,618,441 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure

Shares outstanding: 14.73mShares outstanding, period not labelled, at 2026-08-0514,725,646 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336707.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.